Bayer announces manufacturing layoffs

Oct 05, 2018

Bayer AG announced it will cut 227 jobs connected to its Berkeley, California manufacturing operations, as it preps a new manufacturing plant in Germany.

The layoffs come after Bayer used voluntary packages to eliminate 200 more positions, as the drugmaker shifts hemophilia A patients to next-generation drugs. Bayer won FDA and European regulatory approvals last month for its latest, long-acting hemophilia treatment, Jivi.

Bayer has been phasing out Kogenate — its main hemophilia A drug manufactured in Berkeley for the past two decades — in some markets, such as Canada and parts of the European Union, as it brings online two new blood-clotting drugs.

Read the San Fran Biz Journal Coverage

Don't miss your Daily Dose! Subscribe to the daily eNewsletter

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments